Licensing Strategies for Accessing Biomarker Technologies

Decision Resources
December 7, 2007
28 Pages - SKU: DECR1635635
License type:
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition
5/11/2012 | published by: Kalorama Information
The drug discovery process is long, arduous and costly, which has driven outsourcing in this field. The first phase is discovery of a lead compound, a molecule that affects biological function by binding to a  |  more...
$3,995.00
The Worldwide Market for In Vitro Diagnostic Tests, 8th Edition (pre-publication)
7/20/2012 | published by: Kalorama Information
ESTIMATED AVAILABILITY:  JULY 20TH, 2012  |  more...
$6,500.00
Clinical Lab Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles)
4/30/2012 | published by: Kalorama Information
Since the last time Kalorama Information studied the market for clinical lab services two years ago, there have been substantial changes in the industry, including changes in market share as major companies eat into regional  |  more...
$3,500.00
The Global Market for Medical Devices, 3rd. Edition
5/2/2012 | published by: Kalorama Information
Medical device makers faced a productive but challenging year in 2011. They innovated existing lines, launched new devices and invested in R&D.  But they also experienced funding cutbacks and new taxes and regulations.  |  more...
$2,500.00
In Vitro Diagnostics - A Global Market Overview
5/14/2012 | published by: Industry Experts
`The In Vitro Diagnostic (IVD) industry has been confronting a range of issues, such as regulations, industry consolidation, reforms in healthcare, low level of technological innovations and ever-changing demographics. Though some of these challenges may  |  more...
$4,500.00
Ferring Pharmaceuticals, Inc. – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
Ferring Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Ferring Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on the Ferring Pharmaceuticals, Inc.’s research and development focus. The report  |  more...
$500.00
ADVENTRX Pharmaceuticals, Inc. – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
ADVENTRX Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “ADVENTRX Pharmaceuticals - Product Pipeline Review - 2012” provides data on the ADVENTRX Pharmaceuticals’s research and development focus. The report includes information  |  more...
$500.00
Dainippon Sumitomo Pharma Co., Ltd. – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
Dainippon Sumitomo Pharma Co., Ltd. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Dainippon Sumitomo Pharma Co., Ltd. - Product Pipeline Review - 2012” provides data on the Dainippon Sumitomo Pharma Co., Ltd.’s  |  more...
$500.00
Eli Lilly and Company – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
Eli Lilly and Company – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Eli Lilly and Company - Product Pipeline Review - 2012” provides data on the Eli Lilly and Company’s research and development  |  more...
$500.00
Emergent BioSolutions Inc. – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
Emergent BioSolutions Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Emergent BioSolutions Inc. - Product Pipeline Review - 2012” provides data on the Emergent BioSolutions Inc.’s research and development focus. The report  |  more...
$500.00